BioSpace News Archive

Gossamer Bio, Inc. announced its financial results for the quarter ended March 31, 2019 and provided a corporate update.

CannTrust Holdings Inc. released its financial results for the first quarter ended March 31, 2019.

Sage Therapeutics announced that the Company will present at the 2019 RBC Capital Markets Global Healthcare Conference on Tuesday, May 21, 2019 at 3:35 p.m. EDT in New York, NY.

Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that it has entered into a licensing agreement that grants Iconic Therapeutics, Inc. (Iconic) non-exclusive rights to Zymeworks’ proprietary ZymeLink™ antibody-drug conjugate (ADC) platform for the development of its ICON-2 Tissue Factor ADC for cancer.

SamanTree Medical announced the successful closing of its CHF 9.5 million Series A financing.

Syndax Pharmaceuticals, Inc. announced that Briggs W. Morrison, M.D., Chief Executive Officer of Syndax, will present at the UBS Global Healthcare Conference on Tuesday, May 21, 2019 at 10:30 a.m. ET at the Grand Hyatt New York.

BioLineRx Ltd. reports its financial results for the quarter ended March 31, 2019 and provided a corporate update.

Andrew Alliance and Arcis Biotechnology today announced a co-marketing relationship for deploying protocols that automate sample preparation for nucleic acid analysis on Andrew Alliance platforms.

Soligenix, Inc. announced its recent accomplishments and financial results for the quarter ended March 31, 2019.

Castlight Health, Inc. (NYSE: CSLT) today announced it has added two new solutions to its digital health ecosystem: Virta Health and Vida Health